Who gets the best MS care? study reveals treatment gaps
NCT ID NCT05131984
Summary
This study looked back at medical records to see if people's gender, race, or economic background affected their access to a multiple sclerosis drug called Ocrelizumab and how well the treatment worked for them. Researchers analyzed data from 800 patients at two major hospitals to understand if everyone gets equal care and outcomes. The goal was to identify any unfair differences in who gets treatment and how they respond to it.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE SCLEROSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Brigham and Women's Hospital
Boston, Massachusetts, 02115, United States
Conditions
Explore the condition pages connected to this study.